Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT00003111
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • carboplatin — DRUG
  • cisplatin — DRUG
  • irinotecan hydrochloride — DRUG
  • paclitaxel — DRUG
  • neoadjuvant therapy — PROCEDURE
  • surgical procedure — PROCEDURE
  • radiation therapy — RADIATION

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with irinotecan and cisplatin followed by surgery in treating patients with stage IIIA non-small cell lung cancer.

Key Dates

Start date
Apr 30, 1997
Status verified
Aug 2009
Primary completion
Apr 30, 2004
Completion
Apr 30, 2004

Study Design

Enrollment
10 participants (actual)
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Yale Comprehensive Cancer CenterNew HavenConnecticut06520-8028-

Find similar trials in New Haven, CT

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Yale Comprehensive Cancer Center· New Haven, CT

Related Studies